IMMUNOBIOLOGY OF PANCREATIC ISLET XENOGRAFTING
胰岛异种移植的免疫生物学
基本信息
- 批准号:2466376
- 负责人:
- 金额:$ 18.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-01-01 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:MHC class II antigen SCID mouse T lymphocyte antigen presenting cell apoptosis athymic mouse cellular immunity cytolysins gene targeting genetically modified animals helper T lymphocyte inflammation interferon gamma laboratory rat leukocyte activation /transformation leukocyte adhesion molecules monoclonal antibody pancreatic islet transplantation polymerase chain reaction pore forming protein tissue /cell culture tissue donors transplant rejection transplantation immunology xenotransplantation
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) The goal of the
proposed research is to study the basis of T cell-mediated immune
recognition of xenogeneic cellular grafts, using islets of Langerhans as a
relevant model system. Data obtained during the funding period strongly
suggests that the prevalent mode of xenogenic islet recognition is through
the indirect pathway of antigen recognition by recipient's CD4+ T
lymphocytes.
In Specific Aim I a, several immunodeficient mice will be used to determine
the mechanisms of CD4+ T lymphocyte-dependent xenoreactivity towards rat
islets. The notion that islet xenografts survive in nude and SCID
recipients strongly suggests that, it least in murine recipients, rejection
of such grafts is dependent on T cells. Furthermore, evidence was obtained
during the first funding period that such cellular response is CD4+ T
cell-dependent in vivo. The first goal of this proposal is to analyze the
role of molecules involved in target cell destruction in xenograft rejection
via direct lysis (perforin), via induction of apoptosis (Fas L) and by
mediation of inflammation (IFN-g). Perforin deficient mice (PKO), Fas L
deficient mice (gld/gld) and IFN-g deficient mice will be used as donors of
CD4+ T cells, which will be transferred into RAG1-/- recipients. RAG 1-/-
(T and B cell deficient, not as leaky as SCID mice) recipients will be
previously transplanted with rat islets. The hypothesis tested by this
series of experiments is that CD4 T cell-mediated rejection of xenogeneic
islets requires triggering of inflammation, but it does not require the
presence of intact cell-cytotoxicity mediating molecules. Therefore the
expected results (supported by preliminary findings) are that PKO CD4 cells
will induce rat islet rejection in times similar to those of WT CD4 cells,
while IFN-g-deficient CD4 cells will be significantly less efficient in
mediating graft rejection.
While the pivotal role of CD4+ T cells in xenogeneic islet rejection has
been established, it can not be formally ruled out that non T cell-mediated
effector mechanisms might contribute (partially or entirely) to the observed
phenomena. Specific Aim I b is therefore set forth to explore this working
hypothesis. Specific Aim I c will test the hypothesis that CD4+ T
cell-mediated rejection of xenogeneic grafts might not require T cell
receptor-mediated interaction with the grafted target cells. Specific Aim I
d is focused on the analysis of rejection of discordant islet grafts in the
pig to mouse model system. In Specific Aim II, the P.I. proposes to
investigate the mechanisms that mediate the induction of long term survival
of xenogeneic islets grafted in mice treated with a short course of
anti-LFA-1 antibodies.
描述:(改编自申请人的摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ronald G Gill其他文献
Ronald G Gill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ronald G Gill', 18)}}的其他基金
ISLET CELL RESOURCES TYPE1 DIABETES: TRANSPLANTATION: CYSTIC FIBROSIS
胰岛细胞资源 1 型糖尿病:移植:囊性纤维化
- 批准号:
7167013 - 财政年份:2005
- 资助金额:
$ 18.53万 - 项目类别:
ISLET CELL RESOURCES TYPE1 DIABETES: TRANSPLANTATION: CYSTIC FIBROSIS
胰岛细胞资源 1 型糖尿病:移植:囊性纤维化
- 批准号:
6982949 - 财政年份:2004
- 资助金额:
$ 18.53万 - 项目类别:
Correcting dysregulated peripheral tolerance in NOD mice
纠正 NOD 小鼠失调的外周耐受性
- 批准号:
6730228 - 财政年份:2003
- 资助金额:
$ 18.53万 - 项目类别:
Correcting dysregulated peripheral tolerance in NOD mice
纠正 NOD 小鼠失调的外周耐受性
- 批准号:
6806459 - 财政年份:2003
- 资助金额:
$ 18.53万 - 项目类别:
ISLET CELL RESOURCES (ICR) FAC AT THE UNIVERSITY OF *
* 大学胰岛细胞资源 (ICR) FAC
- 批准号:
7038453 - 财政年份:2001
- 资助金额:
$ 18.53万 - 项目类别:
ISLET CELL RESOURCES (ICR) FAC AT THE UNIVERSITY OF *
* 大学胰岛细胞资源 (ICR) FAC
- 批准号:
6951912 - 财政年份:2001
- 资助金额:
$ 18.53万 - 项目类别:
相似海外基金
Analysis of transmembrane proteins activity in urological cancers using humanized SCID mouse
使用人源化 SCID 小鼠分析泌尿系统癌症中的跨膜蛋白活性
- 批准号:
19K09674 - 财政年份:2019
- 资助金额:
$ 18.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Core B - SCID Mouse : Human Xenograft Core (Jordan Pober, MD/PhDP.I.)
核心 B - SCID 小鼠:人类异种移植核心(Jordan Pober,医学博士/博士)
- 批准号:
6756347 - 财政年份:2004
- 资助金额:
$ 18.53万 - 项目类别:
EXPERIMENTAL ANALYSIS OF VASCULER CHANGES IN CHRONIC ALLOGRAFT REJECTION USING HUMANIZED SCID MOUSE MODEL.
使用人源化 SCID 小鼠模型对慢性同种异体移植排斥中的血管变化进行实验分析。
- 批准号:
14571526 - 财政年份:2002
- 资助金额:
$ 18.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The heat shock protein(HSP) was investigated as the pathogenesis of focal infection with tonsil by the SCID mouse model
通过SCID小鼠模型研究热休克蛋白(HSP)作为扁桃体局灶性感染的发病机制
- 批准号:
14571629 - 财政年份:2002
- 资助金额:
$ 18.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of patient-like SCID mouse model by orthotopically implanting primary cultured cells from surgically-resected lung cancer tissues.
通过原位植入手术切除的肺癌组织的原代培养细胞建立类患者 SCID 小鼠模型。
- 批准号:
14571269 - 财政年份:2002
- 资助金额:
$ 18.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




